1 Introduction According to the American Cancer Society, breast cancer remains the most commonly diagnosed cancer and the second leading cause of cancer-related death among women in the United States in 2025 [1]. Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, with a five-year survival rate of 58% versus 72% for non-TNBC patients [2, 3]. When metastasis develops within three months of diagnosis, the five-year survival rate falls sharply to 25% [4].
Renfei Wu
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Renfei
Contact Renfei, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack